Carmel Biosciences   Report issue

For profit
Founded: Atlanta GA United States (2011)
Status: Acquired by Nutriband (2018)

Organization Overview

First Clinical Trial
2012
NCT01696448
First Marketed Drug
2017
valsartan (diovan)
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CARMEL BIOSCIENCES

Active Ingredients

Marketed Drugs (1)

valsartan (diovan) (2017)

Drugs in Other Trials (2)

alpha-lipoic acid (1 trial)

berberine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2